Power Law company profile

Penumbra

Biotech & Life Sciences · Alameda, United States · Founded 2004 · IPO 2015 Decacorn

Penumbra develops clinically beneficial products that help patients suffering from stroke and other neurovascular diseases

Valuation

$13B

Market cap · May/2026

Revenue

$1.40B

Latest reported FY

EBITDA

$299M

Latest reported FY

Featured in Decacorn$10B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

1 investor on Penumbra's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 1 investor entered at this stage

Fidelity Investments

Penumbra mafia

Startups founded by Penumbra alumni

Former Penumbra employees who went on to start their own companies. Sorted by Dealroom signal score.

CollateEst. 2025

Surbhi SarnaUnited States

Signal score95

Persist AIEst. 2022

Karthik Raman, PhDUnited States

Signal score84

Interline TherapeuticsEst. 2020

MLMatt LuminaisUnited States

Signal score60

Sans Strings StudioEst. 2023

Ryan CornielUnited States

Signal score52

Book a demo to explore the full alumni network →

Global footprint

Where Penumbra has talent and traffic

AI talent share

0.2% of workforce is AI talent
(5 of 3,076 staff)

Core AI00%

Other AI50.16%

Non-AI workforce3,07199.84%

Workforce by country

37 countries with
team presence

🇺🇸 United States85.7%

🇩🇪 Germany3%

🇮🇹 Italy1.5%

🇵🇱 Poland0.9%

🇬🇧 United Kingdom0.8%

Top 5 of 37 shown

Web traffic by country

62K monthly visits
across markets

🇺🇸 United States44.4%

🏳️ Korea8.2%

🏳️ Republic of7.9%

🇦🇺 Australia6.5%

🇨🇦 Canada4.4%

Top 5 markets shown

Patent intelligence

$22M patent portfolio · 48 active families

Estimated portfolio value

$22M

0.17% of market cap · 23.3× smaller than top peer Insulet ($502M)

48 active patent families

Where Penumbra innovates Virtual realityPhysical medicine and rehabilitationVirtual worldNeurorehabilitationTreatment seeking

Where Penumbra concentrates vs peers

Each axis is a top-10 topic across Penumbra and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Penumbra

An AI-synthesized read of the highest-engagement posts about Penumbra on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Penumbra on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles